iSOFT Wins Two Regional Contract Extensions in Spain

iSOFTiSOFT Spain has won two contracts worth a total of €1.35 million with the public healthcare services of Andalusia and the Balearic Islands, with both customers extending their current agreements with the company. The Andalusian healthcare service (SAS) has renewed its contract for maintenance at 16 hospitals for another year in a deal worth €750,000. In addition, the Balearic Islands healthcare service (IB-SALUT) has awarded iSOFT a €600,000 contract extension to roll out its e-prescription solution to all primary care centres and pharmacies in Mallorca and Menorca.

Andalusia
The contract extension with the SAS is for the support, development and preventative maintenance of a range of iSOFT applications at hospitals across Andalusia's regional healthcare service. The initial project was awarded in 2006 and this latest order brings the total value of the work to €2.25 million.

The contract covers 16 of the 28 hospitals operated by the SAS across the Andalusia region. Some hospitals have one iSOFT application while others have the full range. These include x‑HIS (patient management), e-HC (electronic patient record), x-GPC (clinical order management) and departmental solutions such as PAT-Win (pathology), x-UC (intensive care), x‑LOG (logistics), x-LAB (laboratory) and x-FARMA (pharmacy).

Antonio Castillo, iSOFT Spain’s Strategic Accounts Director, said: "This maintenance contract extension is very important for iSOFT and clearly demonstrates that we continue to provide a first-class service and innovative solutions for public hospitals in the Andalusia region."

Balearic Islands
The Balearic Islands healthcare service (IB-SALUT) has awarded iSOFT a €600,000 contract extension to roll out its e-prescription solution to all primary care centres and pharmacies in Mallorca and Menorca, following a successful, award-winning project in Ibiza and Formentera. The total value of this project is €1.7 million after iSOFT won an initial €1.1 million order in 2006.

The e-prescription solution eliminates paper and so saves time, avoids mistakes and improves the monitoring of treatment. It also provides prescribing rules, a recommended list of drugs and automation of payments.

Roll-out to the 43 primary care centres in Mallorca will be completed this month and in the five centres in Menorca by December. Ultimately, the solution will be installed at the 55 health centres and 411 pharmacies across the four Balearic Islands for a population of 1.2 million people.

The latest phase follows successful projects at seven primary care centres in Ibiza and Formentera. During the six-month pilot, the application was used for over 27,500 prescriptions out of nearly 34,500 prescriptions dispensed.

In March this year, the project won the Correo Farmacéutico magazine award for best technology initiative, having won in March of last year the ComputerWorld magazine award for its positive impact on the local population.

Antonio Castillo said: "We have worked very closely with IB-SALUT since 2004 in helping it develop an electronic patient record for primary care and improve services to the people of the Balearic Islands. We are the preferred supplier of primary care systems and our e-SIAP solution is installed at all IB-SALUT's primary care centres, so it is very gratifying to also participate in the e-prescription implementation, an innovative project led by IB-SALUT that will serve as model for other autonomous regions."

Related news articles:

About IBA Health Group
IBA Health Group Limited (ASX-IBA) is the largest specialist information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of over 3,500 healthcare IT experts around the globe.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the Company's website at www.ibahealth.com.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...